Pharming Group (PHAR)
8.333
-0.19
(-2.20%)
USD |
NASDAQ |
Nov 04, 16:00
Pharming Group PE Ratio (Forward)
PE Ratio (Forward) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical PE Ratio (Forward) Data
| Date | Value |
|---|---|
| December 30, 2022 | -- |
| December 29, 2022 | -- |
| December 28, 2022 | -- |
| December 27, 2022 | -- |
| December 23, 2022 | -- |
| December 22, 2022 | -- |
| December 21, 2022 | -- |
| December 20, 2022 | -- |
| December 19, 2022 | -- |
| December 16, 2022 | -- |
| December 15, 2022 | -- |
| December 14, 2022 | -- |
| December 13, 2022 | -- |
| December 12, 2022 | -- |
| December 09, 2022 | -- |
| December 08, 2022 | -- |
| December 07, 2022 | -- |
| December 06, 2022 | -- |
| December 05, 2022 | -- |
| December 02, 2022 | -- |
| December 01, 2022 | -- |
| November 30, 2022 | -- |
| November 29, 2022 | -- |
| November 28, 2022 | -- |
| November 25, 2022 | -- |
| Date | Value |
|---|---|
| November 23, 2022 | -- |
| November 22, 2022 | -- |
| November 21, 2022 | -- |
| November 18, 2022 | -- |
| November 17, 2022 | -- |
| November 16, 2022 | -- |
| November 15, 2022 | -- |
| November 14, 2022 | -- |
| November 11, 2022 | -- |
| November 10, 2022 | -- |
| November 09, 2022 | -- |
| November 08, 2022 | -- |
| November 07, 2022 | -- |
| November 04, 2022 | -- |
| November 03, 2022 | -- |
| November 02, 2022 | -- |
| November 01, 2022 | -- |
| October 31, 2022 | -- |
| October 28, 2022 | -- |
| October 27, 2022 | -- |
| October 26, 2022 | -- |
| October 25, 2022 | -- |
| October 24, 2022 | -- |
| October 21, 2022 | -- |
| October 20, 2022 | -- |
Forward PE Ratio Definition
The Forward Price to Earnings (PE) Ratio is similar to the price to earnings ratio. The regular P/E ratio is a current stock price over its earnings per share. The forward P/E ratio is a current stock's price over its "predicted" earnings per share. If the forward P/E ratio is higher than the current P/E ratio, it indicates decreased expected earnings.
PE Ratio (Forward) Range, Past 5 Years
PE Ratio (Forward) Benchmarks
| uniQure NV | -- |
| ProQR Therapeutics NV | -- |
| Merus NV | -- |
| argenx SE | Upgrade |
| Pharvaris NV | -- |